Vimarsana
Biggest News Aggregation in the World

Page 4 - Ctla 4 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ctla 4. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ctla 4 Today - Breaking & Trending Today

Salk scientists find new immunotherapy treatment for glioblastoma - Vimarsana News

Salk scientists find new immunotherapy treatment for glioblastoma

Glioblastoma, the most common and deadly form of brain cancer, grows rapidly to invade and destroy healthy brain tissue. The tumor sends out cancerous tendrils into the brain that make surgical tumor removal extremely difficult or impossible.

Tails on engineered T cells could help fight cancer - Vimarsana News

Tails on engineered T cells could help fight cancer

In a promising form of immunotherapy known as CAR T-cell (chimeric antigen receptor) therapy, the patient's T cells are engineered to better recognize and attack antigens on the surface of cancer cells.

Tumor-derived GDF-15 suppresses immunotherapy response - Vimarsana News

Tumor-derived GDF-15 suppresses immunotherapy response

Researchers evaluate the impact of tumor-derived GDF-15 on responses to anti-PD-1 immunotherapy.

How lipid metabolites in the gut aid in regulatory T-cell differentiation - Vimarsana News

How lipid metabolites in the gut aid in regulatory T-cell differentiation

Researchers describe the Treg-cell-inducing activity of lipid extracts from the feces of specific-pathogen-free mice.

SWOG investigators report results from DART clinical trial of immunotherapy combination for rare gynecologic cancers - Vimarsana News

SWOG investigators report results from DART clinical trial of immunotherapy combination for rare gynecologic cancers

Results from the S1609 DART clinical trial, which tested an immunotherapy combination of ipilimumab plus nivolumab in 53 cohorts of patients with rare cancers, are being reported for five cohorts of patients who had rare gynecologic cancers.